RIVA, ELISABETTA
 Distribuzione geografica
Continente #
AS - Asia 5.985
NA - Nord America 1.080
EU - Europa 587
SA - Sud America 254
AF - Africa 40
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.972
Nazione #
SG - Singapore 4.695
US - Stati Uniti d'America 1.019
CN - Cina 606
HK - Hong Kong 455
IT - Italia 182
BR - Brasile 180
GB - Regno Unito 180
VN - Vietnam 117
DE - Germania 70
IN - India 40
CA - Canada 39
AR - Argentina 29
NL - Olanda 29
AU - Australia 23
FI - Finlandia 21
ZA - Sudafrica 21
EC - Ecuador 18
UA - Ucraina 18
CZ - Repubblica Ceca 15
ID - Indonesia 15
MX - Messico 14
PL - Polonia 14
TR - Turchia 14
JP - Giappone 10
RU - Federazione Russa 9
ES - Italia 8
FR - Francia 8
PY - Paraguay 7
BD - Bangladesh 6
EE - Estonia 5
MA - Marocco 5
VE - Venezuela 5
BE - Belgio 4
CH - Svizzera 4
CL - Cile 4
CO - Colombia 4
PK - Pakistan 4
SE - Svezia 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
IL - Israele 3
PE - Perù 3
AM - Armenia 2
BF - Burkina Faso 2
HN - Honduras 2
IQ - Iraq 2
KE - Kenya 2
KZ - Kazakistan 2
LT - Lituania 2
MY - Malesia 2
PA - Panama 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BW - Botswana 1
BY - Bielorussia 1
CD - Congo 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
KH - Cambogia 1
KR - Corea 1
LB - Libano 1
LC - Santa Lucia 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MU - Mauritius 1
NO - Norvegia 1
NR - Nauru 1
PT - Portogallo 1
RO - Romania 1
SI - Slovenia 1
SL - Sierra Leone 1
TH - Thailandia 1
TJ - Tagikistan 1
TO - Tonga 1
TW - Taiwan 1
UG - Uganda 1
VG - Isole Vergini Britanniche 1
Totale 7.972
Città #
Hong Kong 454
Singapore 406
Ashburn 284
Hefei 283
Boardman 194
London 156
Beijing 137
Shanghai 98
Dallas 80
Council Bluffs 66
Rome 55
Ho Chi Minh City 52
San Francisco 36
Munich 30
Los Angeles 28
Pune 24
São Paulo 24
Toronto 24
Santa Clara 20
Seattle 20
Washington 18
Amsterdam 17
Hanoi 17
Milan 17
New York 16
West Jordan 15
Warsaw 14
Brno 13
Brooklyn 12
Helsinki 11
Melbourne 10
Sydney 10
Turku 10
Boston 9
Tokyo 9
Chicago 8
Montreal 8
Chennai 7
Johannesburg 7
Quito 7
Brescia 6
Da Nang 6
Guayaquil 6
Haiphong 6
Hải Dương 6
Mexico City 6
Belo Horizonte 5
Hangzhou 5
Manchester 5
Atlanta 4
Bologna 4
Curitiba 4
Ferrara 4
Montevideo 4
Nuremberg 4
Redmond 4
Secaucus 4
Settimo Torinese 4
Sona 4
Stockholm 4
The Dalles 4
Verona 4
Ananindeua 3
Asunción 3
Basel 3
Berlin 3
Biên Hòa 3
Campinas 3
Canberra 3
Cape Town 3
Centurion 3
Charlotte 3
Cotia 3
Denver 3
Guangzhou 3
Haikou 3
Lima 3
Miami 3
Naples 3
Pittsburgh 3
Quảng Ngãi 3
Rio de Janeiro 3
Surbiton 3
Altamura 2
Barcelona 2
Bari 2
Belém 2
Brasília 2
Brussels 2
Buenos Aires 2
Buffalo 2
Bắc Giang 2
Casavatore 2
Falconara Marittima 2
General Escobedo 2
Guarulhos 2
Guiyang 2
Hanover 2
Hortolândia 2
Huế 2
Totale 2.906
Nome #
Real-time polymerase chain reaction with melting analysis of positive blood culture specimens in bloodstream infections: diagnostic value and turnaround time 216
Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples 209
Migrants rescued on the Mediterranean Sea route: nutritional, psychological status and infectious disease control 207
A case of hepatitis B virus infection in Eritrean Diciotti migrant: phylogenetic analysis and 'mirror effect' 206
Impact of IFN lambda 3/4 single nucleotide polymorphisms on the cytomegalovirus reactivation in autologous stem cell transplant patients 205
SARS-CoV-2 Variants in COVID-19 Disease: A Focus on Disease Severity and Vaccine Immunity in Patients Admitted to the Emergency Department 198
Comparison of the Allplex TM Respiratory Panel Assays and the Automated Fast Track Diagnostics Respiratory Pathogens 21 Assay for the Diagnosis of Pediatric Respiratory Viral Infections 196
Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients 196
Alterazioni del sistema interferon in patologie umane: basi biologiche per un intervento terapeutico [The alteration of IFN system in human diseases: Biological basis for a therapy] 191
). Diagnosi Delle Infezioni Virali 182
Hepatitis A virus in a medical setting in Madagascar: a lesson for public health 181
A staphylococcus aureus coinfection on a COVID-19 pneumonia in a breast cancer patient 175
Aspetti virologici della patogenesi dell’infezione da HIV 173
Capitolo 26. Spirochete 164
Epstein–Barr virus, Cytomegalovirus, and Herpes Simplex-1/2 reactivations in critically ill patients with COVID-19 155
Cine¬tica di replicazione dell'HIV su C8166: aspetti biologici ed applicativi. 155
Antibodies to IFN in chronic patients treated with rIFN alpha. 155
Influenza B virus infection complicated by life-threatening pericarditis: A unique case-report and literature review 143
Markers of human papillomavirus infection and their correlation with cervical dysplasia in human immunodeficiency virus-positive women 136
Acquired immunodeficiency virus (HIV-1). Biological aspects and virological diagnosis [Il virus dell'immunodeficienza acquisita (HIV-1). Aspetti biologici e diagnosi virologica] 101
An acute febrile outbreak in a refugee community of an Italian asylum seeker center: lessons learned. Ciccozzi M., Riva E. share co-first authorship 100
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 100
MALDI-TOF MS Identification and Clustering Applied to Enterobacter Species in Nosocomial Setting 98
SARS-CoV-2 AY.4.2 variant circulating in Italy: Genomic preliminary insight 96
Genomic Epidemiology Unveil the Omicron Transmission Dynamics in Rome, Italy 93
Genotype I hepatitis A virus introduction in Italy: Bayesian phylogenetic analysis to date different epidemics 92
Emerging Microorganisms and Infectious Diseases: One Health Approach for Health Shared Vision 90
Cronobacter sakazakii DNA detection in cerebrospinal fluid of a patient with amyotrophic lateral sclerosis mimic syndrome 88
ACE2 expression is related to the interferon response in airway epithelial cells but is that functional for SARS-CoV-2 entry? 88
Classificazione E Struttura Dei Virus Animali 88
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 87
Diffuse maculopapular rash: A family cluster during the last Chikungunya virus epidemic in Italy 85
Biological and clinical significance of neutralizing and binding antibodies to interferon-alpha (IFN-alpha) during therapy for chronic hepatitis C. 85
Classificazione E Struttura Dei Virus 85
Azione antivirale dell'interferon e di altri inibitori naturali. Giornale Italiano di Chemioterapia 84
Cellular factors leading to AZT resistance of HIV. 81
Anti-interferon (IFN) antibodies in patients with relapsing remitting multipla sclerosis treated with recombinant IFN1a or IFN1b 81
Alteration of thymidine kinase activity in cells treated with an antiviral agent. 80
Detection of a SARS-CoV-2 P.1.1 variant lacking N501Y in a vaccinated health care worker in Italy 78
“Classificazione e struttura dei virus” 47
IMMUNOCOMPLESSI CIRCOLANTI (IC) IN PAZIENTI HCV POSITIVI 45
Human Immunodeficiency Virus (HIV) DNA load and the level of immunosuppression in Treatment-Naïve HIV-1 Infected Patients 44
Plasma HIV viremia and viral load in lymph nodes 40
In Vitro Selection Of Human Immunodeficiency Virus Type 1 Resistant To 3'-Azido-3'-Deoxythymidine. 40
Multidrug-Resistant Klebsiella pneumoniae Strains in a Hospital: Phylogenetic Analysis to Investigate Local Epidemiology 38
Spirochete (Cap. 26) 38
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 37
THE NUMBER OF HIV DNA-INFECTED MONONUCLEAR CELLS IS REDUCED UNDER HAART PLUS RECOMBINANT IL-2 37
Correction: Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples 37
Diagnosi Delle Infezioni Virali 36
IS HUMAN IMMUNODEFICIENCY VIRUS RNA LOAD COMPOSED OF NEUTRALIZED IMMUNE COMPLEXES? 36
High detection rate of human papillomavirus in anal brushings from women attending a proctology clinic 35
Patogenesi Dell'infezione Da HIV: Determinazione Quantitativa Del DNA Provirale Nel Monitoraggio Clinico Terapeutico 34
Neutralizing and Nonneutralizing antibodies to IFN in hepatitis patients treated with different IFN alpha preparations. 34
Drug-induced cell mediated mechanism leading to resistance of HIV to AZT 34
Diagnosi delle Infezioni Virali 34
Quantitative hiv-1 proviral DNA detection: a multicentre analysis 33
MIGLIORAMENTO DELLA PERFORMANCE E GESTIONE DELLA ROUTINE MOLECOLARE NEL LABORATORIO DI VIROLOGIA DEL POLICLINICO UNIVERSITARIO CAMPUS BIO-MEDICO (UCBM) ATTRAVERSO L’UTILIZZO DI UN SISTEMA COMPLETAMENTE AUTOMATICO. 33
Sinergismo fra AZT e ddI nell'infezione da HIV-1: aspetti biologici ed applica¬tivi. 33
Influence of Hepatitis C virus (HCV) genotype, HCV RNA load and ALT level on reduction of HCV RNA after a single administration of interferon alpha 32
Lower schooling, higher hepatitis C virus prevalence in Italy: an association dependent on age 32
Fattori di non progressione nell'infezione da HIV. 32
Interleukin-28B (IL-28B) single-nucleotide polymorphisms and interferon plus ribavirin treatment outcome in Italian chronically HCV-infected patients 32
LA COINFEZIONE HIV/HPV 32
Identification of an amino acid substitution involved in the reduction of sensitivity of HIV-1 to an inhibitor of viral proteinase. 31
Evaluation of cellular associated HIV-1 DNA levels in HIV-1 infected patients receiving a long term of highly active antiretroviral therapy 31
STUDIO SULLE MUTAZIONI DI HIV-1 ASSOCIATE A FARMACORESISTENZA NEL PLASMA E NELLE CELLULE MONONUCLEATE DI SANGUE PERIFERICO 31
vitro selection of HIV-1 resistance to ddI is no as efficient as for the other antiretroviral drugs and yields virus which shows reduced cytophatic activity. 31
Susceptibility to measles in migrant population: implication for policy makers. Ceccarelli G., Vita S., Riva E. share co-first authorship 30
Spirochete 30
Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients 30
Studio sulla farmacoresistenza cellulare all'AZT 30
Il virus dell'immunodeficienza acquisita: aspetti biologici e diagnosi virologica. 29
Recovery of hematopoietic activity in bone marrow from human immunodeficiency virus type 1-infected patients during highly active antiretroviral therapy 29
Zidovudine induces the expression of cellular resistance affecting its antiviral activity. 29
IMPACT OF THE IL28B RS12979860 CT POLYMORPHISM ON THE CYTOMEGALOVIRUS REACTIVATION IN AUTOLOGOUS STEM CELL TRANSPLANT PATIENTS 29
Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha 29
Was Aldo Castellani the inventor of combined and polyvalent vaccines? 28
The new Chikungunya virus outbreak in Italy possibly originated from a single introduction from Asia. 28
LYSOSOMAL ACID LIPASE ACTIVITY IS REDUCED IN PATIENTS WITH CIRRHOSIS AND ASSOCIATED WITH SURROGATE INDICES OF PORTAL HYPERTENSION 28
The synergistic interaction of interferon types I and II leads to marked reduction in severe acute respiratory syndrome-associated coronavirus replication and increase in the expression of mrnas for interferon-induced proteins. Intervirology 28
Genomic and Epidemiologic Surveillance of SARS-CoV-2 in the Pandemic Period: Sequencing Network of the Lazio Region, Italy 27
Neutralizing Antibodies against SARS-CoV-2 Beta and Omicron Variants Inhibition Comparison after BNT162b2 mRNA Booster Doses with a New PETIA sVNT Assay 27
Drug combination Of AZT And Ddi: Synergism Of Action And Prevention of Appearance of AZT-Resistance 27
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 27
IMPAIRED 2’-3’-DIDEOXY-3’-THIACYTIDINE ACCUMULATION IN T LYMPHOBLASTOID CELLS AS A MECHANISM OF ACQUIRED RESISTANCE INDEPENDENT OF MULTIDRUG-RESISTANT PROTEIN 4 WITH A POSSIBLE ROLE FOR ATP-BINDING CASSETTE C11 27
The biologiccal basis foer clinical use of interferon in infectious diseases 27
Exploring the Interplay between COVID-19 and Gut Health: The Potential Role of Prebiotics and Probiotics in Immune Support 26
The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients 26
Liver cirrhosis after prolonged therapy with IFN-alpha plus IL-2 in a metastatic renal cancer long-term survivor 26
The SARS-CoV-2 Epidemic: How the Italian Public Is Being Informed 26
MARCATORI MOLECOLARI DELL’INFEZIONE DA HPV IN DONNE HIV-NEGATIVE E HIV-POSITIVE 26
Role of the IL28B Rs12979860 C/T Polymorphism on the Incidence of Clinically-Active Cytomegalovirus Infection in Autologous Stem Cell Transplant Patients 26
IMPROVEMENT OF INTERLEUKIN 2 PRODUCTION, CLONOGENIC CAPABILITY AND RESTORATION OF STROMAL CELL FUNCTION IN HUMAN IMMUNODEFICIENCY VIRUS-TYPE-1 PATIENTS AFTER HIGHLY ACTIVE ANTIRETROVIRAL THERAPY 25
Modifications of HIV-1 DNA and provirus-infected cells during 24 months of intermittent highly active antiretroviral therapy 25
L'infezione persistente di fibroblasti normali produce HIV-1 infettivo a citopatogenicità ridotta. 25
MARCATORI MOLECOLARI DELL’INFEZIONE DA HPV 25
Quando il virus è 'camaleontico. In “LE INFEZIONI VIRALI “ 25
Molecular Characterization of Whole-Genome SARS-CoV-2 from the First Suspected Cases of the XE Variant in the Lazio Region, Italy 24
Fibroblast Growth Factor 21 in Chronic Hepatitis C: A Potential Non-Invasive Biomarker of Liver Status upon Viral Eradication 24
Totale 7.120
Categoria #
all - tutte 60.073
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.073


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022201 0 0 0 0 1 1 1 1 12 6 2 177
2022/202381 3 1 1 2 9 1 4 6 3 8 39 4
2023/2024530 13 62 19 44 59 230 2 22 2 23 7 47
2024/20255.522 84 30 185 49 51 97 82 13 377 392 1.920 2.242
2025/20261.661 431 235 250 445 218 82 0 0 0 0 0 0
Totale 7.995